Skip to main content
Fig. 3 | Systematic Reviews

Fig. 3

From: Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis

Fig. 3

Forest plots of treatments versus placebo for vision gain and vision loss outcomes. Illustration of effect estimates for anti-VEGF agents compared to placebo for the outcomes of vision gain and vision loss. Abbreviations: AFLI, aflibercept; BEVA, bevacizumab; BROL, brolucizumab; CONB, conbercept; DXM, dexamethasone; IVTA, intravitreal triamcinolone acetonide; PDT, photodynamic therapy; PLAC, placebo; RANI, ranibizumab

Back to article page

Systematic Reviews

ISSN: 2046-4053